Skip to content
Two pipettes with red and yellow liquid

Approved treatments for inherited EB

EB Clinet provides an overview of the approved treatment options for EB.

This overview only contains treatments that are initially exclusively authorized for Epidermolysis bullosa (or a specific subtype) and does not include therapies whose indication was expanded to include EB, or whose off-label use may be recommended for EB..

There are other drugs and therapies that are being investigated in clinical trials. Please check the Clinical Trials Database for information on ongoing trials.


Please be aware that the listed drugs might not be approved by every authority or medicines agency or refunded by the insurance system. Please check with your national authorities or patient support organization to get information on availability.

Current overview

FILSUVEZĀ® - Topical gel containing 10% birch triterpenes for DEB and JEB

Learn more about FILSUVEZĀ® Gel

VYJUVEKĀ® - Topical herpes-simplex virus type 1 (HSV-1) vector-based gene therapy for DEB

Learn more about VYJUVEKĀ® Gel

ZEVASKYNĀ® - Autologous cell sheet based gene therapy for RDEB

Learn more about ZEVASKYNĀ®
Back to main navigation